DrugLib.com — Drug Information Portal

Rx drug information, pharmaceutical research, clinical trials, news, and more



Comparison of Estrogen and Methyltestosterone Combination Treatments for Postmenopausal Hot Flushes

Information source: Solvay Pharmaceuticals
Information obtained from ClinicalTrials.gov on June 20, 2008
Link to the current ClinicalTrials.gov record.

Condition(s) targeted: Hot Flushes, Menopause, Postmenopause

Intervention: Esterified Estrogens (EE) and Methyltestosterone (MT) (Drug); Esterified Estrogens (EE) and Methyltestosterone (MT) (Drug); Esterified Estrogens (EE) and Methyltestosterone (MT) (Drug); Esterified Estrogens (EE) and Methyltestosterone (MT) (Drug); Esterified Estrogens (EE) and Methyltestosterone (MT) (Drug); Esterified Estrogens (EE) and Methyltestosterone (MT) (Drug); Esterified Estrogens (EE) and Methyltestosterone (MT) (Drug); Esterified Estrogens (EE) and Methyltestosterone (MT) (Drug); Esterified Estrogens (EE) and Methyltestosterone (MT) (Drug)

Phase: Phase 2

Status: Completed

Sponsored by: Solvay Pharmaceuticals

Official(s) and/or principal investigator(s):
Global Clinical Director Solvay, Study Director, Affiliation: Solvay Pharmaceuticals

Summary

This is a research study to evaluate the effectiveness, safety and side effects of several dose levels of esterified estrogens (EE) and methyltestosterone (MT) given individually and in combination compared to a placebo (a tablet with no active drug in it) as a possible treatment for vasomotor symptoms (such as hot flushes and flushing) of menopause. EE and testosterone are two hormones which are typically deficient in menopausal women

Clinical Details

Official title: A Multi-Center, Double-Blind, Placebo-Controlled Comparison of Multiple Doses of Esterified Estrogens and Methyltestosterone, in Combination and Alone, in Relieving Vasomotor Symptoms in Postmenopausal Women

Study design: Treatment, Randomized, Double Blind (Subject, Investigator), Placebo Control, Parallel Assignment, Safety/Efficacy Study

Primary outcome:

Mean change in frequency of moderate to severe vasomotor symptoms (VMS) from baseline to Week 4

Mean change in frequency of moderate to severe VMS from baseline to Week 12

Mean change in severity of moderate to severe VMS from baseline to Week 4

Mean change in severity of moderate to severe VMS from baseline to Week 12

Secondary outcome:

Frequency and severity of moderate to severe and all hot flushes at each week

Mean change from baseline to Week 12 in the moderate to severe vulvar and vaginal atrophy symptom identified by the subject as most bothersome

Mean change from baseline to Week 12 in vaginal pH

Mean change from baseline to Week 12 in vaginal maturation index (parabasal and superficial cells)

Eligibility

Minimum age: 45 Years. Maximum age: 65 Years. Gender(s): Female.

Criteria:

Inclusion Criteria:

1. Be able to communicate with the Investigator and study staff and be able to complete the required study procedures,

2. Be a female of any race between the ages of 45-65 years, in generally good health,

3. Be either naturally or surgically postmenopausal (with or without a uterus)

Exclusion Criteria:

1. Known sensitivity or contraindications to natural or synthetic estrogens, androgens or progestins,

2. History of or current diagnosis of malignant melanoma, breast cancer or any cancer (except non-melanomatous skin cancer) diagnosed less than 5 years prior to beginning the study

Locations and Contacts

Site 124, Moscow, Russian Federation

Site 125, Moscow, Russian Federation

Site 126, Moscow, Russian Federation

Site 127, St. Petersburg, Russian Federation

Site 128, Moscow, Russian Federation

Site 129, Moscow, Russian Federation

Site 130, Moscow, Russian Federation

Site 131, St. Petersburg, Russian Federation

Site 132, Moscow, Russian Federation

Site 133, Moscow, Russian Federation

Site 134, St. Petersburg, Russian Federation

Site 138, St. Petersburg, Russian Federation

Site 37, Montgomery, Alabama, United States

Site 69, Montgomery, Alabama, United States

Site 44, Tucson, Arizona, United States

Site 6, Jonesboro, Arkansas, United States

Site 62, Little Rock, Arkansas, United States

Site 100, North Vancouver, British Columbia, Canada

Site 116, West Vancouver, British Columbia, Canada

Site 120, Abbotsford, British Columbia, Canada

Site 135, Victoria, British Columbia, Canada

Site 18, San Diego, California, United States

Site 27, San Diego, California, United States

Site 31, Vista, California, United States

Site 54, San Diego, California, United States

Site 68, Walnut Creek, California, United States

Site 70, Carmichael, California, United States

Site 85, Carmichael, California, United States

Site 87, Northridge, California, United States

Site 66, Denver, Colorado, United States

Site 4, Groton, Connecticut, United States

Site 14, Waterbury, Connecticut, United States

Site 35, New Britain, Connecticut, United States

Site 9, Venice, Florida, United States

Site 21, Stuart, Florida, United States

Site 25, Aventura, Florida, United States

Site 26, Aventura, Florida, United States

Site 33, Pensacola, Florida, United States

Site 51, Clearwater, Florida, United States

Site 61, Daytona Beach, Florida, United States

Site 71, Clearwater, Florida, United States

Site 75, Gainesville, Florida, United States

Site 82, Tampa, Florida, United States

Site 83, West Palm Beach, Florida, United States

Site 8, Atlanta, Georgia, United States

Site 23, Atlanta, Georgia, United States

Site 40, Alpharetta, Georgia, United States

Site 55, Savannah, Georgia, United States

Site 60, Powder Springs, Georgia, United States

Site 90, Alpharetta, Georgia, United States

Site 76, Boise, Idaho, United States

Site 58, Chicago, Illinois, United States

Site 64, Champaign, Illinois, United States

Site 72, Chicago, Illinois, United States

Site 74, Chicago, Illinois, United States

Site 50, Evansville, Indiana, United States

Site 52, Baton Rouge, Louisiana, United States

Site 65, Mandeville, Louisiana, United States

Site 73, Metarie, Louisiana, United States

Site 93, Winnipeg, Manitoba, Canada

Site 122, Winnipeg, Manitoba, Canada

Site 15, Lutherville, Maryland, United States

Site 43, Ann Arbor, Michigan, United States

Site 12, Chaska, Minnesota, United States

Site 3, St. Louis, Missouri, United States

Site 16, Kansas City, Missouri, United States

Site 19, Kansas City, Missouri, United States

Site 80, Chesterfield, Missouri, United States

Site 17, Billings, Montana, United States

Site 36, Lincoln, Nebraska, United States

Site 7, Las Vegas, Nevada, United States

Site 28, Reno, Nevada, United States

Site 111, St. John's, Newfoundland and Labrador, Canada

Site 39, New Bern, North Carolina, United States

Site 46, Winston Salem, North Carolina, United States

Site 59, Winston Salem, North Carolina, United States

Site 79, Raleigh, North Carolina, United States

Site 34, Mayfield Heights, Ohio, United States

Site 45, Cincinnati, Ohio, United States

Site 53, Columbus, Ohio, United States

Site 78, Mogadore, Ohio, United States

Site 81, Cincinnati, Ohio, United States

Site 77, Tulsa, Oklahoma, United States

Site 92, Sarnia, Ontario, Canada

Site 95, Hamilton, Ontario, Canada

Site 96, Strathroy, Ontario, Canada

Site 106, Newmarket, Ontario, Canada

Site 107, London, Ontario, Canada

Site 109, Burlington, Ontario, Canada

Site 113, Sarnia, Ontario, Canada

Site 114, Corunna, Ontario, Canada

Site 115, Kingston, Ontario, Canada

Site 117, Peterborough, Ontario, Canada

Site 137, Ottawa, Ontario, Canada

Site 13, Portland, Oregon, United States

Site 89, Portland, Oregon, United States

Site 63, Pottstown, Pennsylvania, United States

Site 84, Philadelphia, Pennsylvania, United States

Site 91, Shawinigan, Quebec, Canada

Site 94, Sainte Foy, Quebec, Canada

Site 103, Rimouski, Quebec, Canada

Site 105, Sherbrooke, Quebec, Canada

Site 112, Montreal, Quebec, Canada

Site 119, Sainte Foy, Quebec, Canada

Site 136, Sherbrooke, Quebec, Canada

Site 22, Warwick, Rhode Island, United States

Site 24, Greenville, South Carolina, United States

Site 67, Hilton Head, South Carolina, United States

Site 10, Chattanooga, Tennessee, United States

Site 56, Nashville, Tennessee, United States

Site 88, Memphis, Tennessee, United States

Site 11, Houston, Texas, United States

Site 20, Corpus Christi, Texas, United States

Site 30, San Antonio, Texas, United States

Site 41, San Antonio, Texas, United States

Site 86, Bryan, Texas, United States

Site 49, Salt Lake City, Utah, United States

Site 2, Norfolk, Virginia, United States

Site 29, Richmond, Virginia, United States

Site 42, Virginia Beach, Virginia, United States

Site 47, Charlottesville, Virginia, United States

Site 48, Richmond, Virginia, United States

Site 5, Seattle, Washington, United States

Site 32, Tacoma, Washington, United States

Site 38, Spokane, Washington, United States

Additional Information

Starting date: June 2005
Ending date: September 2007
Last updated: February 12, 2008

Page last updated: June 20, 2008

-- advertisement -- The American Red Cross
We comply with
HONcode standard.
Verify here.
Home | About Us | Contact Us | Site usage policy | Privacy policy

All Rights reserved - Copyright DrugLib.com, 2006-2009